The forecast for analgesic medicine use in France shows a declining trend from 2024 to 2028. Starting at 83.2 defined daily doses per thousand persons per day in 2024, there is a consistent decrease, indicating a reduction in consumption over these years.
Year-on-year percentage variations highlight this trend, showing a steady decrease: -1.6% from 2024 to 2025, -1.6% from 2025 to 2026, -1.6% from 2026 to 2027, and -1.5% from 2027 to 2028. The compound annual growth rate (CAGR) over this period reflects an average annual decline of around 1.6%.
Future trends to watch for include potential impacts from increased health awareness, shifts towards alternative pain management approaches, and developments in regulatory policies which might influence further reduction or stabilization in usage levels.
